SOURCE: Eli Lilly and CompanyDESCRIPTION:
Today's guest blog comes from Lilly's Vice President of Global Health Programs and Access, Dr. Evan Lee.
Indian health officials continue to grapple with the rise of multidrug-resistant tuberculosis (MDR-TB). The latest data show a marked increase in the number of drug-resistant cases over the past year in Mumbai, India’s most populous city. More than 600 additional people with MDR-TB were put on treatment in 2013 compared to 2012.
Some of that growth is attributable to better diagnostics. In 2013, nearly 3,000 patients in Mumbai were diagnosed with MDR-TB compared with just 181 in 2011. But the number of MDR-TB cases continues to rise. Therefore, the doctors, nurses, clinical staff and pharmacists at the front lines of TB control are more vital than ever before to stopping this global health threat.
KEYWORDS: Health, Eli Lilly and Company, Eli Lilly, Lilly, Corporate Responsibility, MDR-TB, multidrug-resistant tuberculosis, Lilly MDR-TB Partnership, tb